Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: Effects of diet and leptin deficiency

BMC Physiology

Volumn 12, Issue 1, 2012, Pages

  Nyrén, Rakel ^a   Chang, Chuchun L ^b   Lindström, Per ^a   Barmina, Anastasia ^a   Vorrsjö, Evelina ^a   Ali, Yusuf ^c   Juntti Berggren, Lisa ^c   Bensadoun, André ^d   Young, Stephen G ^e   Olivecrona, Thomas ^a   Olivecrona, Gunilla ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Columbia University ^*  (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Department of Obstetrics Gynecology   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Endothelium; Exocrine pancreas; Heparin; High fat diet; Immunofluorescence; Islet cells; Lipoprotein lipase; Ob ob mice; qPCR

Indexed keywords

CD31 ANTIGEN; GLUCAGON; GLYCOSYLPHOSPHATIDYLINOSITOL; GPI HBP1 PROTEIN, MOUSE; GPI-HBP1 PROTEIN, MOUSE; HEPARIN; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CAPILLARY; ENDOTHELIUM CELL; LIPID DIET; MALE; METABOLISM; METHODOLOGY; MOUSE; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL;

ANIMALS; ANTIGENS, CD31; CAPILLARIES; DIET, HIGH-FAT; ENDOTHELIAL CELLS; GLUCAGON; GLUCAGON-SECRETING CELLS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEPARIN; INSULIN; INSULIN-SECRETING CELLS; LEPTIN; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; PANCREAS; RECEPTORS, LIPOPROTEIN;

MLCS; MLOWN;

EID: 84869881208     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-12-14     Document Type: Article

References (35)

1. Lipoprotein lipase: from gene to obesity. Wang H, Eckel RH, Am J Physiol Endocrinol Metab 2009 297 271 E288 10.1152/ajpendo.90920.2008 19318514
2. The ins and outs of adipose tissue. Olivecrona T, Olivecrona G, Cellular lipid metabolism Heidelberg: Springer, Ehnholm C, 2009 315 369
3. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Davies BS, Beigneux AP, Barnes RH 2nd, Tu Y, Gin P, Weinstein MM, Nobumori C, Nyren R, Goldberg I, Olivecrona G, et al. Cell Metab 2010 12 42 52 10.1016/j.cmet.2010.04.016 20620994
4. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, et al. Cell Metab 2007 5 279 291 10.1016/j.cmet.2007.02. 002 17403372
5. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BS, Kuivenhoven JA, et al. Arterioscler Thromb Vasc Biol 2009 29 956 962 10.1161/ATVBAHA.109.186577 19304573
6. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden MR, Gin P, Davies BS, Weinstein MM, Fong LG, et al. J Lipid Res 2010 51 1535 1545 10.1194/jlr.M002717 20026666
7. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Franssen R, Young SG, Peelman F, Hertecant J, Sierts JA, Schimmel AW, Bensadoun A, Kastelein JJ, Fong LG, Dallinga-Thie GM, Beigneux AP, Circ Cardiovasc Genet 2010 3 169 178 10.1161/CIRCGENETICS.109.908905 20124439
8. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. Coca-Prieto I, Kroupa O, Gonzalez-Santos P, Magne J, Olivecrona G, Ehrenborg E, Valdivielso P, J Intern Med 2011 270 224 228 10.1111/j.1365-2796.2011.02361.x 21314738
9. Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells. Davies BS, Goulbourne CN, Barnes RH 2nd, Turlo KA, Gin P, Vaughan S, Vaux DJ, Bensadoun A, Beigneux AP, Fong LG, Young SG, J Lipid Res 2012 53 2690 2697 10.1194/jlr.M031559 23008484
10. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. Marshall BA, Tordjman K, Host HH, Ensor NJ, Kwon G, Marshall CA, Coleman T, McDaniel ML, Semenkovich CF, J Biol Chem 1999 274 27426 27432 10.1074/jbc.274.39.27426 10488074
11. Pancreatic beta-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. Pappan KL, Pan Z, Kwon G, Marshall CA, Coleman T, Goldberg IJ, McDaniel ML, Semenkovich CF, J Biol Chem 2005 280 9023 9029 15637076
12. Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction. Cruz WS, Kwon G, Marshall CA, McDaniel ML, Semenkovich CF, J Biol Chem 2001 276 12162 12168 10.1074/jbc.M010707200 11154699
13. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Yaney GC, Corkey BE, Diabetologia 2003 46 1297 1312 10.1007/s00125-003-1207-4 13680127
14. Life and death decisions of the pancreatic beta-cell: the role of fatty acids. Newsholme P, Keane D, Welters HJ, Morgan NG, Clin Sci (Lond) 2007 112 27 42 10.1042/CS20060115
15. n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ, Arterioscler Thromb Vasc Biol 2009 29 555 561 10.1161/ATVBAHA.108.182287 19201689
16. beta-cell function in obese-hyperglycemic mice [ob/ob Mice]. Lindstrom P, Adv Exp Med Biol 2010 654 463 477 10.1007/978-90-481-3271-3-20 20217510
17. Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue. Ruge T, Sukonina V, Myrnas T, Lundgren M, Eriksson JW, Olivecrona G, Eur J Clin Invest 2006 36 16 21 16919006
18. Immunochemical properties of lipoprotein lipase. Development of an immunoassay applicable to several mammalian species. Olivecrona T, Bengtsson G, Biochim Biophys Acta 1983 752 38 45 10.1016/0005-2760(83)90230-8 6849966
19. Biphasic effects of low-molecular-weight and conventional heparins on chylomicron clearance in rats. Chevreuil O, Hultin M, Ostergaard P, Olivecrona T, Arterioscler Thromb 1993 13 1397 1403 10.1161/01.ATV.13.10.1397 8399075
20. The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma. Davies BS, Waki H, Beigneux AP, Farber E, Weinstein MM, Wilpitz DC, Tai LJ, Evans RM, Fong LG, Tontonoz P, Young SG, Mol Endocrinol 2008 22 2496 2504 10.1210/me.2008-0146 18787041
21. Five stages of evolving beta-cell dysfunction during progression to diabetes. Weir GC, Bonner-Weir S, Diabetes 2004 53 Suppl 3 16 S21 15561905
22. Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion. Khan A, Narangoda S, Ahren B, Holm C, Sundler F, Efendic S, Int J Obes Relat Metab Disord 2001 25 816 821 11439295
23. Leptin increases skeletal muscle lipoprotein lipase and postprandial lipid metabolism in mice. Donahoo WT, Stob NR, Ammon S, Levin N, Eckel RH, Metabolism 2011 60 438 443 10.1016/j.metabol.2010.03.016 20494377
24. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Maingrette F, Renier G, Diabetes 2003 52 2121 2128 10.2337/diabetes.52.8.2121 12882931
25. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Kieffer TJ, Habener JF, Am J Physiol Endocrinol Metab 2000 278 1 E14 10644531
26. Inhibitory effects of leptin on pancreatic alpha-cell function. Tuduri E, Marroqui L, Soriano S, Ropero AB, Batista TM, Piquer S, Lopez-Boado MA, Carneiro EM, Gomis R, Nadal A, Quesada I, Diabetes 2009 58 1616 1624 10.2337/db08-1787 19401420
27. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, Li H, Elmquist JK, Kennedy RT, Kulkarni RN, J Clin Invest 2007 117 2860 2868 10.1172/JCI30910 17909627
28. Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, et al. J Biol Chem 2003 278 36380 36388 10.1074/jbc.M213032200 12835327
29. BCL-6: a possible missing link for anti-inflammatory PPAR-delta signalling in pancreatic beta cells. Kharroubi I, Lee CH, Hekerman P, Darville MI, Evans RM, Eizirik DL, Cnop M, Diabetologia 2006 49 2350 2358 10.1007/s00125-006-0366-5 16896941
30. Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer. Liu G, Ashbourne Excoffon KJ, Wilson JE, McManus BM, Rogers QR, Miao L, Kastelein JJ, Lewis ME, Hayden MR, Hum Gene Ther 2000 11 21 32 10.1089/10430340050016120 10646636
31. Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology. Christophersen B, Nordstoga K, Shen Y, Olivecrona T, Olivecrona G, J Lipid Res 1997 38 837 846 9186902
32. Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. Brunzell JD, Deeb SS, The Metabolic and molecular bases of inherited disease New York: McGraw-Hill, Scriver CR B, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler K, Vogelstein B, 2001 2789 2816
33. Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia. Tamasawa N, Matsui J, Murakami H, Tanabe J, Matsuki K, Ogawa Y, Ikeda Y, Takagi A, Suda T, Diabetes Res Clin Pract 2006 72 6 11 10.1016/j.diabres.2005.08.010 16256241
34. Glucose intolerance and decreased early insulin response in mice with severe hypertriglyceridemia. Ding YL, Wang YH, Huang W, Liu G, Ross C, Hayden MR, Yang JK, Exp Biol Med (Maywood) 2010 235 40 46 10.1258/ebm.2009.009100
35. A morphometric study of the endocrine and exocrine capillaries of the pancreas. Henderson JR, Moss MC, Q J Exp Physiol 1985 70 347 356 3898188